
Shares of dental products maker Dentsply Sirona XRAY.O rise 3.1% to $16.16
Co posts Q2 prelim revenue of $935 million, surpassing analysts' average estimate of $933.1 million, according to data compiled by LSEG
XRAY appoints Daniel Scavilla as CEO, effective August 1
Adjusted EPS for Q2 2025 expected between $0.50 and $0.52, vs. est of $0.50
Including session's move, XRAY stock down 15% YTD